Citation only
via Europe PMC
Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study.
Kim K, Chang Y, Jang HM, Kim H, Yoon S, Ryu S.
GeroScience · 2026
Abstract
Loss of muscle mass and quality (myopenia and myosteatosis) are telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition) and predictors of disability, yet their relationship with biological aging in younger adults is unclear. This prospective cohort study included 165,015 adults (mean age 39.9) who underwent low-dose chest computed tomography (CT) between 2010 and 2020. A longitudinal subset of 61,669 participants had repeated scans (median follow-up 4.1 years). We adopted blood-based Phenotypic Age acceleration (PhenoAgeAccel) and chest radiograph-based biological age acceleration (CXR-AgeAccel). Myopenia and myosteatosis were defined as muscle area and density values more than two standard deviations below young sex-specific reference means. Multivariable multinomial logistic and Cox proportional hazard models estimated associations between biological age acceleration and prevalent or incident muscle abnormalities, adjusting for sociodemographic, lifestyle, and clinical factors. PhenoAgeAccel was associated with higher odds of myopenia (OR 1.16, 95% CI 1.08-1.25), myosteatosis (OR 1.24, 95% CI 1.18-1.29), and combined myopenia-myosteatosis (OR 1.51, 95% CI 1.41-1.63). In longitudinal analyses, PhenoAgeAccel was associated with increased risk of incident myopenia (HR 1.21, 95% CI 1.08-1.35), myosteatosis (HR 1.18, 95% CI 1.09-1.28), and the combined myopenia-myosteatosis (HR 1.29, 95% CI 1.08-1.55). Associations were consistent, though attenuated, with CXR-AgeAccel (OR 1.34, 95% CI 1.20-1.50; HR 1.18, 95% CI 0.96-1.45). Associations persisted among participants < 40 years. Accelerated biological aging measured from routine blood and imaging data was associated with early deterioration in muscle mass and quality. Biological age may represent a practical marker for identifying individuals at risk of early musculoskeletal decline.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s11357-026-02420-7
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
K, K., Y, C., HM, J., H, K., S, Y., & S., R. (2026). Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study. <em>GeroScience</em>. https://doi.org/10.1007/s11357-026-02420-7
Vancouver
K K, Y C, HM J, H K, S Y, S. R. Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study. GeroScience. 2026. doi:10.1007/s11357-026-02420-7.
BibTeX
@article{kim2026Associ,
title = {Association of biological age acceleration with muscle aging phenotype in young and middle-aged adults: a prospective cohort study.},
author = {Kim K and Chang Y and Jang HM and Kim H and Yoon S and Ryu S.},
journal = {GeroScience},
year = {2026},
doi = {10.1007/s11357-026-02420-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2026
Open access · CC-BY
Associations Between 40‐Year Trajectories of BMI and Proteomic and Epigenetic Aging Clocks: Deciphering Nonlinearity and Interactions
Aging cell 2026
Open access · OA
Associations Between 40-Year Trajectories of BMI and Proteomic and Epigenetic Aging Clocks: Deciphering Nonlinearity and Interactions.
Ear and Hearing 2018
Preprint · OA
Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss
medRxiv 2025
Preprint · CC-BY
Comparing Fourteen Consensus Biomarkers of Aging: Epigenetic Pace of Aging as the Strongest Predictor of Mortality in BASE-II
edoc Publication server (Humboldt University of Berlin) 2026
Preprint · CC-BY
Comparing fourteen consensus biomarkers of aging: epigenetic pace of aging as the strongest predictor of mortality in BASE-II
Biomarker Research 2026
Open access · CC-BY